Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Sirolimus can reduce tumor cell size in TSC-related skin tumors, but continuous treatment is needed to maintain benefits.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

JAK inhibition reduces autoimmune issues in Down syndrome.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Imatinib can cause hair loss due to lichen planopilaris.

Erlotinib can cause hair loss and texture changes.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.